Loading
A phase 2/3 trial testing Varegacestat in desmoid tumour, active and no longer recruiting.
A Study of AL102 in Patients With Progressing Desmoid Tumours is a phase 2/3 interventional study registered as NCT04871282, led by Immunome, and active but no longer recruiting on the registry. Official title: RINGSIDE: A Phase 2/3, Randomised, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumours. Planned enrolment is 198 participants (actual). The study started in 2021-09-01 and primary completion is expected in 2025-12-03. No results have been posted on ClinicalTrials.gov.
Shares Immunome, Desmoid tumour.